文献速递慢性肾脏病

eMAP:CKD:慢性肾脏病基层医疗电子诊疗辅助系统

eMAP:CKD: electronic diagnosis and management assistance to primary care in chronic kidney disease.
PubMed 文献 · Nephrol Dial Transplant · 2018-01-01

eMAP:CKD 是一项在 21 家基层医疗诊所开展的试点项目,通过定制软件与电子健康记录整合、实时提示及 CKD 护士支持,按澳大利亚肾脏健康组织(KHA)最佳实践建议进行 CKD 识别与管理。项目 15 个月后,CKD 风险因素识别率(29.40% 对 33.84%,P<0.001)、肾脏健康检测完成率(3.20% 对 4.30%,P<0.001)、电子健康记录中 CKD 诊断录入率(0.48% 对 1.55%,P<0.001)及达到 KHA 推荐管理目标的比例均改善(P<0.001)。

要点

  • eMAP:CKD 通过电子健康记录实时提示与 CKD 护士支持辅助基层 CKD 管理。
  • 15 个月后 CKD 风险因素识别率由 29.40% 升至 33.84%(P<0.001)。
  • 肾脏健康检测完成率由 3.20% 升至 4.30%(P<0.001)。

核心结论

  • eMAP:CKD 试点项目改善了 CKD 风险患者的识别、适当检测与管理,以及电子健康记录中 CKD 诊断的录入,并显示可弥合当前实践与最佳实践之间的差距。

研究设计与样本

  • 试点项目,在 21 家基层医疗诊所实施定制软件与电子健康记录整合,并提供 CKD 护士访视支持和教育模块。
  • 基线分析患者 150910 例,项目实施 15 个月后分析患者 175917 例。

主要发现

  • CKD 风险因素识别率从基线 29.40% 升至 15 个月时 33.84%(P<0.001)。
  • 肾脏健康检测完成率从基线 3.20% 升至 15 个月时 4.30%(P<0.001)。
  • 电子健康记录中录入的 CKD 诊断率从基线 0.48% 升至 15 个月时 1.55%(P<0.001)。
  • 达到 KHA 推荐管理目标的患者比例增加(P<0.001)。

关键数值与推荐

  • 软件按澳大利亚肾脏健康组织(KHA)最佳实践建议进行实时提示,涵盖 CKD 风险因素识别、检测、诊断和管理。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The increasing burden of chronic kidney disease (CKD) underpins the importance for improved early detection and management programs in primary care to delay disease progression and reduce mortality rates. eMAP:CKD is a pilot program for primary care aimed at addressing the gap between current and best practice care for CKD. METHODS: Customized software programs were developed to integrate with primary care electronic health records (EHRs), allowing real-time prompting for CKD risk factor identification, testing, diagnosis and management according to Kidney Health Australia's (KHA) best practice recommendations. Primary care practices also received support from a visiting CKD nurse and education modules. Patient data were analyzed at baseline (150 910 patients) and at 15 months (175 917 patients) following the implementation of the program across 21 primary care practices. RESULTS: There was improvement in CKD risk factor recognition (29.40 versus 33.84%; P < 0.001) and more complete kidney health tests were performed (3.20 versus 4.30%; P < 0.001). There were more CKD diagnoses entered into the EHR (0.48 versus 1.55%; P < 0.001) and more patients achieved KHA's recommended management targets (P < 0.001). CONCLUSION: The eMAP:CKD program has shown an improvement in identification of patients at risk of CKD, appropriate testing and management of these patients, as well as increased documentation of CKD diagnosis entered into the EHRs. We have demonstrated efficacy in overcoming the verified gap between current and best practice in primary care. The success of the pilot program has encouraging implications for use across the primary care community as a whole.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Pefanis A, Botlero R, Langham RG, et al. eMAP:CKD: electronic diagnosis and management assistance to primary care in chronic kidney disease. Nephrol Dial Transplant. 2018. PMID: 27789783. doi:10.1093/ndt/gfw366

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。